Показано 0 из 0
Дата |
---|
23:15 |
02.05.2024 |
01.05.2024 |
30.04.2024 |
29.04.2024 |
26.04.2024 |
25.04.2024 |
24.04.2024 |
23.04.2024 |
22.04.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
2.01
|
2.08
|
2.03
|
2.01
|
2.12
|
2.04
|
|
|
118 158.47
|
547.00
|
2.00
|
2.05
|
1.96
|
1.94
|
2.045
|
2.01
|
|
|
166 901.30
|
518.00
|
1.86
|
1.93
|
1.82
|
1.80
|
1.97
|
1.93
|
|
|
134 927.72
|
520.00
|
1.78
|
1.84
|
1.89
|
1.81
|
1.96
|
1.81
|
|
|
220 458.18
|
698.00
|
1.88
|
1.97
|
1.79
|
1.76
|
1.98
|
1.91
|
|
|
169 384.86
|
564.00
|
1.77
|
1.84
|
1.79
|
1.73
|
1.84
|
1.76
|
|
|
546 357.41
|
903.00
|
1.78
|
1.80
|
1.88
|
1.76
|
1.91
|
1.78
|
|
|
368 378.53
|
1 279.00
|
1.87
|
1.90
|
1.96
|
1.875
|
1.98
|
1.88
|
|
|
138 227.85
|
578.00
|
1.95
|
1.98
|
1.99
|
1.945
|
2.02
|
1.945
|
|
|
211 979.09
|
688.00
|
1.97
|
2.01
|
1.91
|
1.91
|
2.02
|
1.97
|
|
|
225 340.78
|
1 005.00
|
Amylyx Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases.